Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Cline Christopher R.CHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $370 9 sh |
| Apr 15, 2026 traded Apr 14, 2026 |
| 16 | Schrock Iman AjPresident | Tax withholding | F | $71K 1,621 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 16 | Robinson Dashiell IDirector, President | Option exercise | M | $125K 20.9K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 16 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $853 20 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 16 | Barnes Wendy LynnDirector, See Remarks | Tax withholding | F | $112K 50.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 15 | Kutua LubiCFO, Treasurer | Open-market sale · 10b5-1 plan | SELL | $253K 419.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 15 | Moyes Kari G.Vice President - CHRO | Grant or award | A | $302K 15.2K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 15 | Murray Michael AndrewDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $526K 187.9K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 15 | Fordyce MarshallDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $617K 14.1K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 14 | Rick LarsenDJoint | Exchange | EXCH | $1,001 – $15K | Apr 15, 2026 traded Mar 31, 2026 |
| 14 | Rick LarsenDJoint | CNL Healthcare Properties Inc (widely held) Exchange | EXCH | $1,001 – $15K | Apr 15, 2026 traded Mar 31, 2026 |
| 14 | Siebel Thomas MDirector, Executive Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.40M 165.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Yuan Eric S.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $46K 550 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | McGinnis Christopher ASee Remarks | Option exercise | M | — 37.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $39K 4,000 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $373K 14.1K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 51.2K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 111.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 115.1K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $36K 4,000 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Hing ChristiCHIEF ACCOUNTING OFFICER | Tax withholding | F | $11K 5,590 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Siebel Thomas MDirector, Executive Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | $665K 326.2K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Haines John RSenior Exec Vice President | Option exercise | M | — 1,641 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Clary RebeccaVP & Chief Financial Officer | Grant or award | A | — 9,524 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | McGinnis Christopher ASee Remarks | Tax withholding | F | $24K 10.7K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Macomber Sasha G.Chief Human Resource Officer | Option exercise | M | $48K 8,031 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $43K 1,018 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Yuan Eric S.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $13K 155 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Geissler WernerDirector | Tax withholding | F | $32K 4,572 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Brigido StephenPres., Functional Regeneration | Option exercise | M | — 821 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Merrill GaryChief Financial Officer | Grant or award | A | — 12.3K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Gingras Christopher RaymondDirector | Other acquisition or disposition | J | $1,075 43 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Siu Hera KDirector | Grant or award | A | $180K 25.6K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Maroney Dawn ChristinePresident | Open-market sale · 10b5-1 plan | SELL | $626K 30.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $1,017 28 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Saak Aaron WDirector | Grant or award | A | $150K 2,262 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Gingras Christopher RaymondDirector | Other acquisition or disposition | J | $541 35 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Bexiga Annabelle GDirector | Open-market sale · 10b5-1 plan | SELL | $153K 1,500 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Wessel MichaelDirector | Grant or award | A | $180K 25.6K sh | Apr 15, 2026 traded Apr 13, 2026 |